● Recruiting

Blood and Urine HPVDNA as Minimally Invasive Biomarkers for Cervical Cancer Detection and Surveillance Following Treatment

Condition: Cervical Cancer · Sponsor: UNC Lineberger Comprehensive Cancer Center

PhaseN/A

Planned participants30

Who can joinFemale, 18 Years to no upper limit

Healthy volunteersNo

About this study

The purpose of this study is to determine if ctHPVDNA (circulating tumor HPV DNA) can be used as a non-invasive biomarker for identification and treatment monitoring of cervical cancer by characterizing correlation between plasma ctHPVDNA, urine transrenal HPVDNA (TrHPVDNA) levels and presence of cervical cancer at diagnosis and following definitive intent management.

This description comes directly from the study's public registry record.

Talk to the study team

Melissa E Knutsen · 919-445-4869 · melissa_knutsen@med.unc.edu

Always discuss trial participation with your own doctor first.

Locations (2)

Melissa Knutsen	Chapel Hill, North Carolina, United States	Recruiting
Kamuzu Central Hospital	Lilongwe, Malawi	Not Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04743674